NCT03693612 2024-08-28GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsGlaxoSmithKlinePhase 1/2 Completed26 enrolled 47 charts
NCT02324608 2023-12-20Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin CancerRutgers, The State University of New JerseyPhase NA Completed15 enrolled 11 charts